Literature DB >> 16432586

Molecular basis of breast cancer.

Layla J Al-Mansouri1, Majed S Alokail.   

Abstract

Breast cancer is the most frequent cancer in women and represents the second leading cause of cancer death among women after lung cancer. A common phenotypic abnormality of breast cancer cells is dysregulation of cell cycle control. The transformation of normal cell to a cancer cell appears to depend on mutation in genes that normally control cell cycle progression, thus leading to loss of the regulatory cell growth. We summarize here the molecular regulation of mammary carcinoma with regards to the most prominent oncogenes and tumor suppressor genes and their outcome in terms of cellular prognosis, and tumor development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16432586

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  3 in total

1.  Effects of PPARγ agonistrosiglitazone on human retinoblastoma cell in vitro and in vivo.

Authors:  Xianyong Cao; Lin He; Yanhua Li
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  Thiazolidinediones as anti-cancer agents.

Authors:  Carmelo Blanquicett; Jesse Roman; C Michael Hart
Journal:  Cancer Ther       Date:  2008

3.  Circular RNA hsa_circ_0068033 Acts as a Diagnostic Biomarker and Suppresses the Progression of Breast Cancer Through Sponging miR-659.

Authors:  Pengfei Yuan; Liangliang Lei; Shuaijun Dong; Dechun Liu
Journal:  Onco Targets Ther       Date:  2020-03-04       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.